Order Article Reprints

Galus W, Kaczmarczyk A, Walawska-Hrycek A, Siuda J, Polewka M, Lasek-Bal A, Puz P. Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers. Medicina. 2025; 61(9):1568. https://doi.org/10.3390/medicina61091568

Galus, Weronika, Aleksandra Kaczmarczyk, Anna Walawska-Hrycek, Joanna Siuda, Milena Polewka, Anetta Lasek-Bal, and Przemysław Puz. 2025. "Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers" Medicina 61, no. 9: 1568. https://doi.org/10.3390/medicina61091568

Galus, W., Kaczmarczyk, A., Walawska-Hrycek, A., Siuda, J., Polewka, M., Lasek-Bal, A., & Puz, P. (2025). Real-World Data of First 12-Months of Ofatumumab Treatment in Multiple Sclerosis Patients—A Multicenter Experience from Tertiary Referral Centers. Medicina, 61(9), 1568. https://doi.org/10.3390/medicina61091568